Drug profile · INN
serelaxin
REASANZ
serelaxin (REASANZ) is a relaxin receptor 2 activator.
EMA: refused Cardiovascular system (C01) C01DX21
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — serelaxin
- Class
- Cardiovascular system (C01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
serelaxin (REASANZ) is a relaxin receptor 2 activator.
Key facts
INN serelaxin
Brand REASANZ
Mechanism Relaxin receptor 2 activator
Target Relaxin receptor 1
Therapeutic class Cardiovascular system (C01)
ATC code C01DX21
Mechanism of action
Relaxin receptor 2 activator
Primary target: Relaxin receptor 1
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | refused | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is serelaxin?
serelaxin (REASANZ) is a relaxin receptor 2 activator.
What is the brand name for serelaxin?
REASANZ is a marketed brand name for serelaxin. Check FDA Drugs@FDA for the current US label holder and prescribing information.